drugset / Trial / NCT05944952

Low-dose Versus a High-dose Sublingual Buprenorphine Induction

NCT05944952 ↗

Phase 4 Active not recruiting 40 enrolled Friends Research Institute, Inc. MATClinics · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

This study proposes to compare a low-dose versus a high-dose buprenorphine induction scheme in 40 fentanyl using people with Opioid Use Disorder (OUD). Study participants will be randomized to either the low-dose (n=20) or high dose (n=20) group and dispensed medication daily for one week.

Timeline

Start
2024-06-20
Primary completion
2024-12-31
Completion
2025-10-30

Drugs

EvaluationDrugModalityDoseRoute
Subject buprenorphine/naloxone Unknown 8 mg Other
Subject buprenorphine/naloxone Unknown 12 mg Other